Stay updated with breaking news from Aapge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) has been assigned an average recommendation of “Buy” from the six research firms that are covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokerages that have covered the stock in the […]
Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) shares reached a new 52-week high on Wednesday . The company traded as high as $23.16 and last traded at $23.07, with a volume of 138737 shares traded. The stock had previously closed at $22.22. Wall Street Analyst Weigh In APGE has been the subject of a […]
Several brokerages have updated their recommendations and price targets on shares of Apogee Therapeutics (NASDAQ: APGE) in the last few weeks: 8/8/2023 – Apogee Therapeutics is now covered by analysts at TD Cowen. They set an “outperform” rating on the stock. 8/8/2023 – Apogee Therapeutics is now covered by analysts at Wedbush. They set an […]
TD Cowen initiated coverage on shares of Apogee Therapeutics (NASDAQ:APGE – Free Report) in a research note released on Tuesday morning, Marketbeat.com reports. The firm issued an outperform rating on the stock. APGE has been the topic of several other research reports. Guggenheim began coverage on shares of Apogee Therapeutics in a research report on […]
Equities research analysts at TD Cowen initiated coverage on shares of Apogee Therapeutics (NASDAQ:APGE – Get Free Report) in a report released on Tuesday, Briefing.com reports. The firm set an “outperform” rating on the stock. A number of other research firms have also recently weighed in on APGE. Jefferies Financial Group started coverage on Apogee […]